Brain

Study Finds Link Between Brain Injury and Criminal Behavior

Study shows criminality is associated with damage to a key brain pathway involved in emotional control and judgment  AURORA, Colo.,…

5 months ago

From Lab to Living Room: New Nonprofit Helps Families Deepen Emotional Connection at Home

Science-backed tools help parents and children connect—improving emotional well-being and reducing behavior struggles NEW YORK, July 10, 2025 /PRNewswire/ --…

5 months ago

Cognition Therapeutics Completes End-of-Phase 2 Meeting with FDA for Zervimesine (CT1812) in Alzheimer’s Disease

Positive Discussion on Path Forward for Registrational ProgramPURCHASE, N.Y., July 10, 2025 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., (the Company…

5 months ago

BriaCell Reports Complete and Sustained Resolution of Brain Metastasis and Sustained Regression of Orbital Metastasis in “Eye-Bulging” Breast Cancer Patient

[IMAGES BELOW] Sustained complete resolution of temporal lobe brain metastasis and continued orbital tumor reduction after >18 months of treatment“Eye…

5 months ago

Diagonal Therapeutics Announces Publication of Data Characterizing the Healthcare System Cost and Impact of Hereditary Hemorrhagic Telangiectasia (HHT) in the American Journal of Hematology

WATERTOWN, Mass., July 10, 2025 (GLOBE NEWSWIRE) -- Diagonal Therapeutics, a biotechnology company focused on correcting dysregulated signaling with clustering…

5 months ago

Rakovina Therapeutics Highlights Strength of Scientific Advisory Board Driving Innovation in AI-Enabled Oncology Drug Development

VANCOUVER, British Columbia, July 10, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (“Rakovina” or the “Company”) (TSX-V: RKV) (FSE: 7JO0),…

5 months ago

EY US announces John Lippert of Scientia Vascular as an Entrepreneur Of The Year® 2025 Mountain West Award winner

Celebrating the bold leaders shaping the future through the world's most ground-breaking companies WEST VALLEY, Utah, July 9, 2025 /PRNewswire/…

5 months ago

Zhimeng Biopharma’s Next-Generation KCNQ2/3 Potassium Channel Opener Receives Clinical Trial Approval for ALS Phase 2/3 Study

SHANGHAI, July 9, 2025 /PRNewswire/ -- Shanghai Zhimeng Biopharma, Inc. ("Zhimeng Biopharma"), a clinical-stage biopharmaceutical company dedicated to innovative drug…

5 months ago

Apollo Biowellness, Inc., Outlook for the Remainder of 2025

North Bergen, New Jersey--(Newsfile Corp. - July 9, 2025) - Apollo Biowellness, Inc. (OTC Pink: KOAN) (the "Company"), as previously…

5 months ago